Evidence map›Paper›PMID 34848832›Full record

ArticleModern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc2022

Development and validation of a vascularity-based architectural classification for clear cell renal cell carcinoma: correlation with conventional pathological prognostic factors, gene expression patterns, and clinical outcomes.

Chisato Ohe, Takashi Yoshida, Mahul B Amin, Naho Atsumi, Junichi Ikeda, Kazuho Saiga, Yuri Noda, Yoshiki Yasukochi, Riuko Ohashi, Haruyuki Ohsugi and 3 more

Erratum issuedAbstract read
PubMed Publisher
In one paragraph

Article in Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.9field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 29 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 2 countries.

Chisato OheDepartment of Pathology, Kansai Medical University, Hirakata, Osaka, 573-1191, Japan. ohec@hirakata.kmu.ac.jp.
Takashi YoshidaDepartment of Urology and Andrology, Kansai Medical University, Hirakata, Osaka, 573-1191, Japan.
Mahul B AminDepartment of Pathology and Laboratory Medicine, University of Tennessee Health Sciences Center, 930 Madison Avenue, Memphis, TN, 38163, USA.
Naho AtsumiDepartment of Pathology, Kansai Medical University, Hirakata, Osaka, 573-1191, Japan.
Junichi IkedaDepartment of Pathology, Kansai Medical University, Hirakata, Osaka, 573-1191, Japan.
Kazuho SaigaDepartment of Pathology, Kansai Medical University, Hirakata, Osaka, 573-1191, Japan.
Yuri NodaDepartment of Pathology, Kansai Medical University, Hirakata, Osaka, 573-1191, Japan.
Yoshiki YasukochiGenome Analysis, Institute of Biomedical Science, Kansai Medical University, 2-3-1 Shin-machi, Hirakata, Osaka, 573-1191, Japan.
Riuko OhashiHistopathology Core Facility, Faculty of Medicine, Niigata University, Niigata, 951-8510, Japan.
Haruyuki OhsugiDepartment of Urology and Andrology, Kansai Medical University, Hirakata, Osaka, 573-1191, Japan.
Koichiro HigasaGenome Analysis, Institute of Biomedical Science, Kansai Medical University, 2-3-1 Shin-machi, Hirakata, Osaka, 573-1191, Japan.
Hidefumi KinoshitaDepartment of Urology and Andrology, Kansai Medical University, Hirakata, Osaka, 573-1191, Japan.
Koji TsutaDepartment of Pathology, Kansai Medical University, Hirakata, Osaka, 573-1191, Japan.
Kansai Medical University · JPNiigata University · JPUniversity of Southern California · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The prognostic significance of an architectural grading system for clear cell renal cell carcinoma (ccRCC) has recently been demonstrated. The present study aimed to establish a vascularity-based architectural classification using the cohort of 436 patients with localized ccRCC who underwent extirpative surgery and correlated the findings with conventional pathologic factors, gene expression, and prognosis. First, we assessed architectural patterns in the highest-grade area on hematoxylin and eosin-stained slides, then separately evaluated our surrogate score for vascularity. We grouped nine architectural patterns into three categories based on the vascular network score. "Vascularity-based architectural classification" was defined: category 1: characterized by enrichment of the vascular network, including compact/small nested, macrocyst/microcystic, and tubular/acinar patterns; category 2: characterized by a widely spaced-out vascular network, including alveolar/large nested, thick trabecular/insular, papillary/pseudopapillary patterns; category 3: characterized by scattered vascularity without a vascular network, including solid sheets, rhabdoid and sarcomatoid patterns. Adverse pathological prognostic factors such as TNM stage, WHO/ISUP grade, and necrosis were significantly associated with category 3, followed by category 2 (all p < 0.001). We successfully validated the classification using The Cancer Genome Atlas (TCGA) cohort (n = 162), and RNA-sequencing data available from TCGA showed that the angiogenesis gene signature was significantly enriched in category 1 compared to categories 2 and 3, whereas the immune gene signature was significantly enriched in category 3 compared to categories 1 and 2. In univariate analysis, vascularity-based architectural classification showed the best accuracy in pathological prognostic factors for predicting recurrence-free survival (c-index = 0.786). The predictive accuracy of our model which integrated WHO/ISUP grade, necrosis, TNM stage, and vascularity-based architectural classification was greater than conventional risk models (c-index = 0.871 vs. 0.755-0.843). Our findings suggest that the vascularity-based architectural classification is prognostically useful and may help stratify patients appropriately for management based on their likelihood of post-surgical recurrence.

Indexed as

Carcinoma, Renal CellKidney NeoplasmsGene ExpressionHumansNecrosisPrognosis

Identifiers

PMID34848832
OpenAlexW3216136557

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.